tiprankstipranks
Hyundai Pharmaceutical Co., Ltd. (KR:004310)
:004310
South Korea Market
004310
Hyundai Pharmaceutical Co., Ltd.
RESEARCH TOOLSreports

Hyundai Pharmaceutical Co., Ltd. (004310) Financial Statements

― Followers

Hyundai Pharmaceutical Co., Ltd. Financial Overview

Hyundai Pharmaceutical Co., Ltd.'s market cap is currently ₩303.60B. The company's EPS TTM is ₩162.84; its P/E ratio is 60.30; and it has a dividend yield of 0.31%. Hyundai Pharmaceutical Co., Ltd. is scheduled to report earnings on ―, and the estimated EPS forecast is ₩―. See an overview of income statement, balance sheet, and cash flow financials.
Nov 25Nov 24Nov 23Nov 22Nov 21
Income Statement
Total Revenue₩ 191.79B₩ 175.74B₩ 180.76B₩ 162.69B₩ 139.80B
Gross Profit₩ 78.23B₩ 73.37B₩ 75.24B₩ 68.84B₩ 56.31B
Operating Income₩ 3.30B₩ 180.89M₩ 6.93B₩ 7.97B₩ -1.57B
EBITDA₩ 7.58B₩ 3.94B₩ 13.21B₩ 10.04B₩ 670.96M
Net Income₩ 2.52B₩ -574.89M₩ 6.12B₩ -164.58M₩ -3.17B
Balance Sheet
Cash & Short-Term Investments₩ 2.50B₩ 10.55B₩ 18.64B₩ 34.53B₩ 22.21B
Total Assets₩ 166.90B₩ 156.40B₩ 154.63B₩ 181.16B₩ 163.86B
Total Debt₩ 50.06B₩ 48.08B₩ 39.20B₩ 39.44B₩ 29.84B
Net Debt₩ 47.56B₩ 37.80B₩ 23.00B₩ 9.18B₩ 8.22B
Total Liabilities₩ 84.80B₩ 77.32B₩ 69.63B₩ 94.60B₩ 77.26B
Stockholders' Equity₩ 82.10B₩ 79.07B₩ 84.66B₩ 86.56B₩ 86.60B
Cash Flow
Free Cash Flow₩ -4.73B₩ -13.56B₩ -10.65B₩ 5.04B₩ -1.68B
Operating Cash Flow₩ -123.29M₩ -2.37B₩ -4.55B₩ 11.62B₩ 5.13B
Investing Cash Flow₩ -8.37B₩ -9.66B₩ -3.09B₩ -9.99B₩ -27.75M
Financing Cash Flow₩ 720.97M₩ 6.10B₩ -6.43B₩ 7.01B₩ 3.25B
Currency in KRW

Hyundai Pharmaceutical Co., Ltd. Earnings and Revenue History

Income Statement >

Hyundai Pharmaceutical Co., Ltd. Debt to Assets

Balance Sheet >

Hyundai Pharmaceutical Co., Ltd. Cash Flow

Cash Flow >

Hyundai Pharmaceutical Co., Ltd. Forecast EPS vs Actual EPS

Earnings >